[1]
“Non-Pharmacological and Pharmacological Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): An Update”, Mugda Med. Coll. J., vol. 7, no. 2, pp. 119–126, Feb. 2025, doi: 10.3329/mumcj.v7i2.78800.